Should Quidel Be Your Next Coronavirus Buy?
If there's one silver lining to the global coronavirus pandemic it's increased appreciation for quick and easy infectious disease testing. Quidel (NASDAQ: QDEL) was already a leader in the market for point-of-care diagnostic equipment before launching COVID-19 tests.
It's hard to know how long to expect explosive demand for coronavirus testing, but it's just a matter of time before Quidel's explosive new revenue stream settles down. Does Quidel have what it takes to deliver market-beating gains into the long run?
Image source: Getty Images.
Source Fool.com
